ARTICLE | Top Story
AC Immune prices $66M IPO
September 22, 2016 7:00 AM UTC
Neurodegeneration company AC Immune S.A. (NASDAQ:ACIU) raised $66 million through the sale of 6 million shares at $11 in an IPO underwritten by Credit Suisse, Jefferies and Leerink. The price valued the company at $609.4 million. AC Immune expects its shares to begin trading on Friday.
On Wednesday, AC Immune said it hoped to sell 6 million shares at $11-$13. Last week, it proposed to sell 4.5 million shares at the same price range. ...